Position in ALKS
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$60,742,916
+$52,268,151 QoQ
Shares Held
1,159,216
+383.7% QoQ
Ownership
0.691%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#33
of 423 holders
Holding Since
Jun 2025
5 quarters on record
Voting authority
Sole 94%
Shared 0%
None 6%
Common Shares in ALKS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026BNP PARIBAS ASSET MANAGEMENT Holding S.A. holds $480,515,408 across 25 Drug Manufacturers - Specialty & Generic names. ALKS ranks #3 (12.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NBIX |
Neurocrine Biosciences Inc
|
1,494,259 | $251,842,409 | |
| 2 | ZTS |
Zoetis Inc.
|
1,173,974 | $84,361,770 | |
| 3 | ALKS |
Alkermes plc.
This page
|
1,159,216 | $60,742,916 | |
| 4 | TEVA |
Teva Pharmaceutical Industries Ltd
|
976,103 | $33,070,368 | |
| 5 | UTHR |
UNITED THERAPEUTICS Corp
|
44,851 | $24,301,615 | |
| 6 | VTRS |
Viatris Inc
|
828,396 | $13,154,927 | |
| 7 | INDV |
Indivior Pharmaceuticals, Inc.
|
94,458 | $3,875,610 | |
| 8 | PBH |
Prestige Consumer Healthcare Inc.
|
72,383 | $3,421,543 |
All Filings in ALKS
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $60,742,916 | 1,159,216 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $8,474,765 | 239,671 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $6,746,901 | 241,133 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $53,310 | 1,777 | Shares | Defined | 2025-11-07 | |
| 2025-06-30 | $49,466 | 1,729 | Shares | Defined | 2025-08-06 | |
| No filing history on record for this holder in this stock. | ||||||